Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine
Roger S. McIntyre, Orly Lipsitz, Leanna M.W. Lui, et al.
Journal of Affective Disorders (2021) Vol. 294, pp. 592-596
Closed Access | Times Cited: 14

Showing 14 citing articles:

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune, et al.
World Psychiatry (2023) Vol. 22, Iss. 3, pp. 394-412
Open Access | Times Cited: 265
A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review
Sabrina Wong, Angela T.H. Kwan, Kayla M. Teopiz, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 698-705
Closed Access | Times Cited: 10
Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamine
Balwinder Singh, Jennifer L. Vande Voort, Vanessa Pazdernik, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 534-540
Closed Access | Times Cited: 7
Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression
Farhan Fancy, Nelson B. Rodrigues, Joshua D. Di Vincenzo, et al.
Bipolar Disorders (2022) Vol. 25, Iss. 2, pp. 99-109
Closed Access | Times Cited: 27
A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)
R. Hamish McAllister‐Williams, Nicola Goudie, Lumbini Azim, et al.
Journal of Psychopharmacology (2025)
Open Access
Prediction of individual treatment allocation between electroconvulsive therapy or ketamine using the Personalized Advantage Index
Benjamin Wade, Ryan Pindale, James Luccarelli, et al.
npj Digital Medicine (2025) Vol. 8, Iss. 1
Open Access
Ketamine for bipolar depression: an updated systematic review
Farhan Fancy, Sipan Haikazian, Danica E. Johnson, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 5
Improving Identification and Treatment Outcomes of Treatment-Resistant Depression Through Measurement-Based Care
Taryn L. Mayes, Amber E. Deane, Hayley Aramburu, et al.
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 2, pp. 227-245
Closed Access | Times Cited: 4
Exploring the Utility of a Machine Learning Approach with Mobile‐Based Cognitive Function Tasks for Detecting Depression
Momoka Takeshige, Taiki Oka, Mai Ohwan, et al.
Japanese Psychological Research (2024)
Open Access | Times Cited: 1
Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants
Christian Yavorsky, Elizabeth D. Ballard, Mark Opler, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 3
Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence
Joshua D. Di Vincenzo, Orly Lipsitz, Nelson B. Rodrigues, et al.
Journal of Psychiatric Research (2021) Vol. 143, pp. 209-214
Closed Access | Times Cited: 6
Examining the impact of comorbid posttraumatic stress disorder on ketamine's real-world effectiveness in treatment-resistant depression
Danica E. Johnson, Nelson B. Rodrigues, S Weisz, et al.
European Neuropsychopharmacology (2024) Vol. 91, pp. 69-77
Open Access
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression
Farhan Fancy, Nelson B. Rodrigues, Joshua D. Di Vincenzo, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2023) Vol. 21, Iss. 4, pp. 420-429
Closed Access
Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index
Benjamin Wade, Ryan Pindale, Joan A. Camprodon, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top